X4 Pharmaceuticals Inc. (XFOR)
NASDAQ · Healthcare
X4 Pharmaceuticals Inc. Long Term Debt 2018–2025
X4 Pharmaceuticals Inc. annual long term debt history from 2018 to 2025. Long term debt refers to financial obligations that are due more than one year in the future.
- X4 Pharmaceuticals Inc. long term debt as of December 31, 2025: 75.0M, a 0.00% increase year-over-year.
- X4 Pharmaceuticals Inc. long term debt for 2025 were 75.0M, a 0.00% increase from 2024.
- X4 Pharmaceuticals Inc. long term debt for 2024 were 75.0M, a 36.36% increase from 2023.
- X4 Pharmaceuticals Inc. long term debt for 2023 were 55.0M, a 69.23% increase from 2022.
- X4 Pharmaceuticals Inc. long term debt for 2022 were 32.5M.
Long Term Debt
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| X4 Pharmaceuticals Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2025 | $75 |
| 2024 | $75 |
| 2023 | $55 |
| 2022 | $33 |
| 2021 | $33 |
| 2020 | $33 |
| 2019 | $20 |
| 2018 | $10 |
X4 Pharmaceuticals Inc. Long Term Debt — FAQ
X4 Pharmaceuticals Inc. (XFOR) long term debt over the last 8 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see XFOR's long term debt history?
The chart and table above show X4 Pharmaceuticals Inc.'s long term debt by year and by quarter, including the growth rate.